US2011257147A1PendingUtilityA1

Neurotherapeutic treatment for sexual dysfunction

63
Assignee: REVAAX PHARMACEUTICALS LLCPriority: Jun 18, 2001Filed: Jun 27, 2011Published: Oct 20, 2011
Est. expiryJun 18, 2021(expired)· nominal 20-yr term from priority
Inventors:Gary A. Koppel
A61K 31/545A61K 31/546A61K 31/43A61K 31/5365A61P 15/10A61K 31/431A61K 31/424
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for improving sexual function is described. A mammal suffering from sexual dysfunction or otherwise in need of enhanced sexual function is administered a compound selected from those that are capable of inhibiting the activity of β-lactams, penicillin-binding protein, carboxypeptidase. Such compounds, including particularly β-lactam ring-containing compounds, can be used to formulate pharmaceutical formulations useful for improving sexual function.

Claims

exact text as granted — not AI-modified
1 . A method for improving sexual function in a mammal suffering from or disposed to develop sexual dysfunction or otherwise in need of enhanced sexual function, said method comprising the step of administering to said mammal a β-lactam compound capable of inhibiting the activity of a bacterial enzyme selected from β-lactamase or penicillin binding protein or a carboxypeptidase, where the β-lactam compound is administered in an amount therapeutically effective to treat the sexual dysfunction or enhance the sexual function of said mammal. 
     
     
         2 .- 31 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.